New Super Bowl commercials in 2026 featuring GLP-1 drugs and tennis icon Serena Williams may help normalize their use, and reshape a conversation that's often driven by misunderstanding.
The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...
Dietary supplements are not approved for safety or efficacy by the U.S. Food and Drug Administration (FDA), and ingredients ...
Though lab-made peptides are touted as a cure-all, they are not FDA-regulated and pose serious risks, experts warn ...
GLP-1 drugs like Ozempic and Wegovy are often portrayed as sudden breakthroughs, but their roots extend back more than a ...
Popular weight-loss drugs like Ozempic and Wegovy can dramatically curb appetite, but experts warn many users are flying blind when it comes to nutrition. New research suggests people taking these ...
In the world of obesity research, the arrival of GLP-1 drugs like Ozempic feels seismic. At a recent conference, Martin Binks, a leader in obesity research, found himself marveling with a colleague: ...
Health experts are urging caution over a fast‑growing online trend involving a bright‑blue liquid substance and self‑administered injections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results